Evidence map›Paper›PMID 40291115›Full record

ArticleToxicological research2025

Cd stabilizes HIF-1α under normoxic conditions via lysine-63-linked ubiquitination and induces ER stress and cell proliferation.

Abderrahmen Chargui, Imen Hammami, Abeer Hashem, Amal A Al-Hazzani, Elsayed Fathi Abd Allah, Amin Belaid, Salem Marzougui, Michèle V Elmay, Baharia Mograbi

Abstract read
In one paragraph

Article in Toxicological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. From environmental exposure to retinal pathology: epidemiological and mechanistic insights into multi-metal driven ocular diseases.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Article
  3. Protective Effects ofJournal of microbiology and biotechnology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Abderrahmen CharguiUniversité de Jendouba, Ecole Supérieure d'Agriculture du Kef (ESAK), LR: Appui à la durabilite des systemes de production agricoles du Nord-Ouest, 7119 Le Kef, Tunisia.ORCID 0000-0003-2346-0010
Imen HammamiLaboratory of Population Health, Environmental Aggressors and Alternative Therapies (LR24ES10), Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Abeer HashemBotany and Microbiology Department, College of Science, King Saud University, P.O. Box 2460, 11451 Riyadh, Saudi Arabia.
Amal A Al-HazzaniBotany and Microbiology Department, College of Science, King Saud University, P.O. Box 2460, 11451 Riyadh, Saudi Arabia.
Elsayed Fathi Abd AllahPlant Production Department, College of Food and Agricultural Sciences, King Saud University, P.O. Box 2460, 11451 Riyadh, Saudi Arabia.
Amin BelaidInstitute of Research on Cancer and Aging in Nice (IRCAN), CNRS, INSERM, FHU OncoAge Centre Antoine Lacassagne Université Côte d'Azur, 06189 Nice, France.
Salem MarzouguiUniversité de Jendouba, Ecole Supérieure d'Agriculture du Kef (ESAK), LR: Appui à la durabilite des systemes de production agricoles du Nord-Ouest, 7119 Le Kef, Tunisia.
Michèle V Elmay *Laboratory of Population Health, Environmental Aggressors and Alternative Therapies (LR24ES10), Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Baharia Mograbi *Institute of Research on Cancer and Aging in Nice (IRCAN), CNRS, INSERM, FHU OncoAge Centre Antoine Lacassagne Université Côte d'Azur, 06189 Nice, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cadmium, a carcinogenic and toxic substance released into the environment, has emerged as a potent activator of lysine-63 ubiquitination, and lysine-63 is a crucial regulator of signal transduction pathways. Although critical, very little information is currently available about how the activation of lysine 63 ubiquitination by Cd might contribute to cancers and inflammatory diseases. The present study provides the first evidence that Cd stabilizes hypoxia-inducible factor-1-alpha, a transcription factor, under normoxic conditions via lysine 63 ubiquitination. Cd induces the accumulation of lysine 63 polyubiquitinated proteins. Importantly, Cd-induced ubiquitination does not prevent oxidative damage or proteasome impairment. Instead, we demonstrated that Cd activates lysine 63 ubiquitination and amplifies its accumulation by overloading the capacity of the autophagy pathway, thus promoting endoplasmic reticulum stress and cell death. At the molecular level, Cd-induced lysine 63 polyubiquitination is correlated with the stabilization of hypoxia-inducible factor-1-alpha, which translocates into the nucleus and promotes the expression of oncogenes such as interleukin 8 and vascular endothelial growth factor. Strikingly, prolonged cell exposure to high Cd concentrations induces increased lysine-63 polyubiquitination, which promotes aggresome formation, thus preventing this protein from interacting with its downstream nuclear targets. Our results showed that Cd is an activator of K63-linked ubiquitination that stabilizes and promotes the accumulation of HIF-1α, which blocks autophagy, thus resulting in endoplasmic reticulum stress. In addition, a small amount of HIF-1α was observed in the nucleus. We therefore propose that the aberrant activation of lysine 63 polyubiquitination by the carcinogen Cd could promote cell proliferation and inflammation at low levels, while high levels lead to cell death. Supplementary Information: The online version contains supplementary material available at 10.1007/s43188-024-00266-9.

Indexed as

CadmiumER stressHIF-1αLysine 63 polyubiquitinationProliferation

Identifiers

PMID40291115
PMCPMC12021772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.